CannBioRx Life Sciences Corp. (ATNFW)
USD 0.01
(5.63%)
USD 0.01
(5.63%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -105.67 Thousand USD | 3.05% |
| 2022 | -109 Thousand USD | 6.27% |
| 2021 | -116.29 Thousand USD | 7.21% |
| 2020 | -125.33 Thousand USD | -73.49% |
| 2019 | -72.24 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -23.98 Thousand USD | -1.72% |
| 2024 Q1 | -23.57 Thousand USD | -116.44% |
| 2023 Q4 | 143.37 Thousand USD | 538.53% |
| 2023 FY | -105.67 Thousand USD | 3.05% |
| 2023 Q3 | -32.69 Thousand USD | -14.51% |
| 2023 Q2 | -28.55 Thousand USD | -31.13% |
| 2023 Q1 | -21.77 Thousand USD | 42.11% |
| 2022 FY | -109 Thousand USD | 6.27% |
| 2022 Q4 | -37.6 Thousand USD | -371.63% |
| 2022 Q3 | -7974.00 USD | 78.43% |
| 2022 Q2 | -36.96 Thousand USD | -39.67% |
| 2022 Q1 | -26.46 Thousand USD | -14.27% |
| 2021 Q2 | -29.52 Thousand USD | -2.98% |
| 2021 FY | -116.29 Thousand USD | 7.21% |
| 2021 Q1 | -28.66 Thousand USD | 0.0% |
| 2021 Q4 | -23.15 Thousand USD | 33.74% |
| 2021 Q3 | -34.95 Thousand USD | -18.39% |
| 2020 Q4 | - USD | 0.0% |
| 2020 FY | -125.33 Thousand USD | -73.49% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | -72.24 Thousand USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| BIMI International Medical Inc. | 1.94 Million USD | 105.419% |
| China Jo-Jo Drugstores, Inc. | 31.1 Million USD | 100.34% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 90.55 Million USD | 100.117% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 90.55 Million USD | 100.117% |
| Leafly Holdings, Inc. | 37.45 Million USD | 100.282% |
| Leafly Holdings, Inc. | 37.45 Million USD | 100.282% |
| LifeMD, Inc. | 126.01 Million USD | 100.084% |
| LifeMD, Inc. | 126.01 Million USD | 100.084% |
| TRxADE HEALTH, Inc. | 2.59 Million USD | 104.067% |
| PetMed Express, Inc. | 78.64 Million USD | 100.134% |
| Walgreens Boots Alliance, Inc. | 26.52 Billion USD | 100.0% |